Gilead Sciences is a top pharmaceutical company based in California, USA
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.
Report: Partnering Deals and Alliances with Gilead Sciences
Gilead Sciences is a top pharmaceutical company based in California, USA.
The company was founded in 1987.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.
Since its inception in 1987, the company has primarily concentrated on antiviral drugs to treat patients infected with HIV, hepatitis B, or influenza.
In 2006, Gilead completed two acquisitions that allowed the company to branch out from its historical antiviral franchise into the cardiovascular and respiratory therapeutic arenas.
The company has always focused on advancing innovations that provide better options and outcomes, enabling healthier lives.
Gilead Sciences has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Gilead has a long history of partnering, building numerous collaborative partnerships more
Gilead Sciences announced over 64 partnering / licensing deals since 2005, with over 20 deals in 2006 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in antivirals, cardiovascular, cancer, followed respiratory and liver diseases more
Gilead Sciences has also announced over 9 M&A deals since 2005, with the lead deals being the acquisition of Myogen, Inc. for $2.5 Billion and Corus Pharma for $365 Million which marked the entry of Gilead in cardiovascular and respiratory markets more
Report: Partnering Deals and Alliances with Gilead Sciences
Examples of recent partnering and licensing deals announced by Gilead Sciences can be viewed in Current Partnering’s Partnering Agreements with Gilead Sciences 2005-2013 activity review article.
Examples of recent M&A deals announced by Gilead Sciences can be viewed in Current Partnering's Partnering Deals and Alliances with Gilead Sciences activity review article.
Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Gilead Sciences
See also
Available reports from Current Partnering
Report: Partnering Deals and Alliances with Gilead Sciences
Report: Partnering Deals and Alliances with Big Pharma
Available resources for deal coverage for Gilead Sciences
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Read: more on Gilead Sciences company profile, recent partnering, M&A and financing news and articles
Related
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk